Funded Tech Companies

Syros Pharmaceuticals

Wondering who backed Syros Pharmaceuticals? Private investors, WuXi PharmaTech and Fidelity Management & Research Company invested in this innovative biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Syros Pharmaceuticals (Nasdaq: SYRS) is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. Syros has pioneered world-leading gene control research and drug discovery capabilities.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

1/18/2018

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Nancy Simonian

        

Chief Financial Officer

Joseph Ferra

        

Chief Medical Officer

David Roth

        

Chief Scientific Officer

Eric Olson

        

VP - Bus. Development

Jeremy Springhorn

        

VP - General Counsel

Gerald Quirk

        

Company Investors

• WuXi PharmaTech
• Fidelity Management & Research Company
• Alexandria Venture Investments
• Deerfield Capital (Jonathan Leff)
• Polaris Partners
• Aisling Capital
• Casdin Capital
• Redmile Group
• Arch Venture Partners (Robert Nelsen)
• Flagship Pioneering

Browse more funded tech companies:

Syrius Robotics | Syrup Tech

Share this article

About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary